Recombinant Human TNK Tissue-type Plasminogen Activator for Injection ·

Recombinant human TNK tissue plasminogen activator for injection is a biological agent used for thrombolytic therapy in patients with acute myocardial infarction within 6 hours of onset.

The active ingredient of this product is a glycoprotein that can directly activate plasminogen to convert into plasmin. When administered intravenously, it is relatively inactive in the circulatory system, and is activated after binding to fibrin, inducing plasminogen to convert into plasmin, leading to fibrin degradation and clot dissolution.

Combination of drugs

Reasonable drug combination can enhance the efficacy or reduce adverse drug reactions, otherwise it can lead to reduced efficacy or increased toxicity, and some abnormal reactions may occur, interfere with treatment, and aggravate the condition. Therefore, when patients use the drug, do not use it in combination with other drugs privately to avoid drug interactions. If you want to use it with other drugs at the same time, please consult a doctor or pharmacist before use.